From Yahoo Finance: 2025-06-07 09:40:00

BofA raised Owens & Minor’s price target to $7.50 from $7 and maintains an Underperform rating after the company and Rotech Healthcare decided to end their merger. The move was unexpected but allows Owens & Minor to focus on core operations. BofA sees the decision positively for the company’s future growth.

Source: TheFly

For more information on OMI, visit the Disclaimer & Disclosure page.

Check out the top stocks recommended by analysts for further investment opportunities.

Read more: Owens & Minor price target raised to $7.50 from $7 at BofA